M. García‐Delgado

Author

M. García‐Delgado

Also Known As

M Garcia-Delgado, M. Garcia-Delgado, M. García-Delgado, M. García‐Delgado, Marina Garcia-Delgado, Marina García-Delgado, Marina García‐Delgado, Marina Garcı́a-Delgado, Martha S. García-Delgado, Martha Susana García-Delgado

Publications

734

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra

About

M. García‐Delgado is an author at Universidad de Navarra specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	253
2	Cell Biology	4	4	135
3	Natural Sciences	2	2	174
4	Biochemistry	1	1	92
5	Cellular Physiology	1	1	92

M. García‐Delgado

Publications

408

Citations

H-Index

Page 1

	Year	Citations
Human, rat and chicken small intestinal Na<sup>+</sup>‐Cl<sup>−</sup>‐creatine transporter: functional, molecular characterization and localization M. García‐Delgado, M. L. Calonge, Juan M. Durán, The Journal of Physiology Creatine TransporterDigestive TractCellular PhysiologyMolecular PharmacologyMolecular Characterization	2002	92
Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients Xabier Agirre, J.L. Vizmanos, Marı́a José Calasanz, Oncogene ChromatinCcwgg MotifsNatural SciencesEpigenetic ChangeDna Methylation	2003	82
<i>TP53</i> is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia Xabier Agirre, Francisco J. Novo, Marı́a José Calasanz, Molecular Carcinogenesis	2003	69
Identical Intragenic MicrosateUite Haplotype Found in Cystic Fibrosis Chromosomes Bearing Mutation G551D in Irish, English, Scottish, Breton and Czech Patients Siobhan M. Cashman, M. García‐Delgado, Z Miedzybrodzka, Human Heredity	1995	46
Higher Sensitivity of Denaturing Gradient Gel Electrophoresis than Sequencing in the Detection of Mutations in DNA from Tumor Samples M. García‐Delgado, Carlos J. González-Navarro, M.C. Napal, BioTechniques Dna SequencingTumor SamplesSomatic VariantTumor HeterogeneityHigher Sensitivity	1998	26
Mutational activation of ras genes is absent in pediatric osteosarcoma Federico Antillón‐Klussmann, M. García‐Delgado, I Villa-Elízaga, Cancer Genetics and Cytogenetics Tumor BiologySomatic VariantOncogenic AgentPathologyRas Genes	1995	23
CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2 Paula Aranaz, C. Hurtado, I. Erquiaga, Haematologica	2012	22
LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation C. Hurtado, I. Erquiaga, Paula Aranaz, Leukemia Research V617fjak2 MutationSomatic VariantPathologySh2 DomainsCancer Genetics	2011	20
Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV) J.L. Vizmanos, Carlos J. González-Navarro, Francisco J. Novo, Journal of Viral Hepatitis	1998	18
A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes Paula Aranaz, C. Ormazábal, Cristina Hurtado, Cancer Genetics and Cytogenetics Hematological MalignancyMedicineTyrosine KinaseHematologyPathology	2010	10

Page 1